XENETIC BIOSCIENCES, INC. (XBIO) Total liabilities 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) total liabilities at each fiscal year-end, per SEC filings.
$968,025FY2025 · since FY2016: $4.8M → $968,025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $968,025 | +8.2% |
| FY2024 | $894,263 | +10.5% |
| FY2023 | $809,585 | -24.6% |
| FY2022 | $1.1M | -24.5% |
| FY2021 | $1.4M | +47.4% |
| FY2020 | $963,971 | -77.8% |
| FY2019 | $4.3M | -4.1% |
| FY2018 | $4.5M | -7.1% |
| FY2017 | $4.9M | +1.2% |
| FY2016 | $4.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIO financial trends
XBIO RevenueXBIO Net incomeXBIO Net marginXBIO Gross profitXBIO Gross marginXBIO Operating incomeXBIO Operating marginXBIO Operating cash flowXBIO Free cash flowXBIO Capital expendituresXBIO Return on equityXBIO Stock buybacksXBIO Dividends paidXBIO Total assetsXBIO Shareholders’ equityXBIO overview →